Log in

3681 SinoMab Bioscience Ltd. HKEX · Hong Kong

SinoMab Bioscience (3681) news

SinoMab Bioscience Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 3681, recorded under Hong Kong. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest SinoMab Bioscience news

We have not published a story on SinoMab Bioscience yet. When there is news, it will appear here.

Questions about SinoMab Bioscience

What is the ticker symbol of SinoMab Bioscience?

SinoMab Bioscience Ltd. trades under the ticker 3681 on HKEX.

Where is SinoMab Bioscience listed?

SinoMab Bioscience Ltd. is listed on HKEX. Our directory also records these other listings: GETTEX:4VF.

Which country or territory is SinoMab Bioscience listed under?

Our directory records SinoMab Bioscience Ltd. under Hong Kong.

What does SinoMab Bioscience do?

Our directory classifies SinoMab Bioscience Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of SinoMab Bioscience?

The ISIN recorded for SinoMab Bioscience Ltd. is HK0000544194.

Does aibio.space cover SinoMab Bioscience?

aibio.space lists SinoMab Bioscience Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to SinoMab Bioscience?

Companies in our directory listed in the same country and business area as SinoMab Bioscience: Sirnaomics, China NT Pharma Group Co., Genscript Biotech, CPBIO Holding Company, Sino Biopharmaceutical, Regent Pacific Group.

Investor discussion: SinoMab Bioscience

Members talk about SinoMab Bioscience (3681). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at SinoMab Bioscience, newest first. Each line links the filing it comes from.

  1. Mergers

    Transaction under the Listing Rules: (1) MAJOR TRANSACTION - DISPOSAL OF SUZHOU PROPERTY AND FACILITY; AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING. Source

  2. Mergers

    Transaction under the Listing Rules: FURTHER DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION. Source

  3. Mergers

    Transaction under the Listing Rules: DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION. Source

  4. Mergers

    Transaction under the Listing Rules: MAJOR TRANSACTION DISPOSAL OF SUZHOU PROPERTY AND FACILITY. Source

  5. Financings

    Share or debt issue: COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. Source

  6. Financings

    Share or debt issue: COMPLETION OF CERTAIN SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. Source

  7. Financings

    Share or debt issue: SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. Source

  8. Financings

    Share or debt issue: COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. Source

  9. Financings

    Share or debt issue: SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE. Source

Press releases

Headlines of SinoMab Bioscience's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    Notification Letter to Non-registered Shareholders and Reply Form

  2. HKEXnews

    Notification Letter to Registered Shareholders and Reply Form

  3. HKEXnews

    SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO 2025 ANNUAL REPORT

  4. HKEXnews

    POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 7 SEPTEMBER 2026

  5. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026

  6. HKEXnews

    Documents on Display

  7. HKEXnews

    NOTICE OF EXTRAORDINARY GENERAL MEETING

  8. HKEXnews

    (1) MAJOR TRANSACTION - DISPOSAL OF SUZHOU PROPERTY AND FACILITY; AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING

  9. HKEXnews

    BOOK CLOSURE PERIOD FOR THE EXTRAORDINARY GENERAL MEETING

  10. HKEXnews

    RESIGNATION OF EXECUTIVE DIRECTOR

  11. HKEXnews

    FURTHER DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION

  12. HKEXnews

    DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION

  13. HKEXnews

    GRANT OF SHARE OPTIONS

  14. HKEXnews

    MAJOR TRANSACTION DISPOSAL OF SUZHOU PROPERTY AND FACILITY

  15. HKEXnews

    APPOINTMENT OF EXECUTIVE DIRECTOR

  16. HKEXnews

    POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 12 JUNE 2026 AND APPOINTMENT OF NON-EXECUTIVE DIRECTOR

  17. HKEXnews

    VOLUNTARY ANNOUNCEMENT PRESENTATION OF PRECLINICAL STUDIES OF ANTI-CGC ANTIBODY (hC2) AT SID ANNUAL MEETING 2026

  18. HKEXnews

    NOTICE OF 2026 ANNUAL GENERAL MEETING

  19. HKEXnews

    VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSED IN PHASE 2 CLINICAL TRIAL OF SM17 FOR ATOPIC DERMATITIS IN CHINA

  20. HKEXnews

    RESIGNATION OF NON-EXECUTIVE DIRECTORS

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:3681 on TradingView.

Listing details

SinoMab Bioscience Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 3681, recorded under Hong Kong. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
SinoMab Bioscience Ltd.
Ticker
3681
Listing
HKEX
Country or territory
Hong Kong
Business scope
Biotechnology
ISIN
HK0000544194
Other listed symbols
GETTEX:4VF
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.